Detalles de la búsqueda
1.
Undernutrition as a risk factor for tuberculosis disease.
Cochrane Database Syst Rev
; 6: CD015890, 2024 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38860538
2.
(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Cochrane Database Syst Rev
; 3: CD013498, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33662147
3.
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial.
Cardiovasc Diabetol
; 19(1): 150, 2020 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979921
4.
Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus.
Calcif Tissue Int
; 107(2): 160-169, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32468187
5.
Metformin monotherapy for adults with type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 6: CD012906, 2020 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32501595
6.
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 11: CD013516, 2020 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33210751
7.
Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 12: CD008558, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31794067
8.
Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 4: CD012368, 2019 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30998259
9.
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
Cochrane Database Syst Rev
; 10: CD012661, 2018 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30371961
10.
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 5: CD012204, 2017 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28489279
11.
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 12: CD003054, 2017 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29205264
12.
Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 4: CD012106, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27101360
13.
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Cochrane Database Syst Rev
; 10: CD012151, 2016 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27749986
14.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (11): CD008143, 2013 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-24214280
15.
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (4): CD009008, 2013 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-23633364
16.
A WHO key informant language survey of people with lived experiences of diabetes: Media misconceptions, values-based messaging, stigma, framings and communications considerations.
Diabetes Res Clin Pract
; 193: 110109, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36183868
17.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (6): CD008143, 2011 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21678374
18.
WITHDRAWN: Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (7): CD008143, 2015 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26222248
19.
WITHDRAWN: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (7): CD009008, 2015 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26222249
20.
Kidney health within the broader non-communicable disease agenda.
Nat Rev Nephrol
; 20(7): 424-425, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38760475